We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+3.43%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$10.5B
AUM Growth
+$2.57B
(+32%)
Cap. Flow
+$2.52B
Cap. Flow
% of AUM
23.97%
Top 10 Holdings %
Top 10 Hldgs %
3.28%
Holding
3,782
New
851
Increased
1,449
Reduced
1,127
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$38.7M |
| 2 |
Amazon
AMZN
|
+$33.2M |
| 3 |
International Paper
IP
|
+$32.8M |
| 4 |
XYZ
Block Inc
XYZ
|
+$32.6M |
| 5 |
Capital One
COF
|
+$30.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$28M |
| 2 |
Dick's Sporting Goods
DKS
|
+$27.9M |
| 3 |
Eli Lilly
LLY
|
+$24.9M |
| 4 |
Vail Resorts
MTN
|
+$24.7M |
| 5 |
Accenture
ACN
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.79% |
| 2 | Financials | 13.65% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Healthcare | 12.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
2851
Kalaris Therapeutics
KLRS
$93.3M
| $276K | ﹤0.01% |
927
+165
| +22% | +$76.5K |
|
|
TBSAU
2852
DELISTED
TB SA Acquisition Corp Unit
TBSAU
| $276K | ﹤0.01% |
+27,901
| New | +$277K |
|
|
XLNX
2853
DELISTED
Xilinx Inc
XLNX
| $276K | ﹤0.01% |
1,304
-1,813
| -58% | -$358K |
|
|
CERE
2854
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $275K | ﹤0.01% |
8,486
-9,323
| -52% | -$329K |
|
|
NP
2855
DELISTED
Neenah, Inc. Common Stock
NP
| $275K | ﹤0.01% |
+5,940
| New | +$291K |
|
|
STR
2856
DELISTED
Sitio Royalties
STR
| $274K | ﹤0.01% |
14,082
+10,163
| +259% | +$217K |
|
|
GXIIU
2857
DELISTED
GX Acquisition Corp. II Unit
GXIIU
| $274K | ﹤0.01% |
+27,800
| New | +$275K |
|
2858
Afya
AFYA
$1.23B
| $273K | ﹤0.01% |
+17,354
| New | +$279K |
|
2859
Celsius Holdings
CELH
$6.66B
| $272K | ﹤0.01% |
10,941
-103,053
| -90% | -$2.85M |
|
|
GBIO
2860
DELISTED
Generation Bio
GBIO
| $272K | ﹤0.01% |
3,842
+2,554
| +198% | +$446K |
|
2861
Upbound Group
UPBD
$1.13B
| $272K | ﹤0.01% |
5,666
+176
| +3% | +$8.8K |
|
2862
Bausch Health
BHC
$2.39B
| $271K | ﹤0.01% |
9,802
-93,886
| -91% | -$2.51M |
|
2863
Freedom Holding
FRHC
$9.56B
| $271K | ﹤0.01% |
3,912
-16,901
| -81% | -$1.14M |
|
2864
Logitech
LOGI
$15.1B
| $271K | ﹤0.01% |
3,286
-26,486
| -89% | -$2.21M |
|
2865
RadNet
RDNT
$6.07B
| $271K | ﹤0.01% |
9,007
-43,910
| -83% | -$1.29M |
|
|
RNAM
2866
DELISTED
Avidity Biosciences
RNAM
| $271K | ﹤0.01% |
11,401
-4,127
| -27% | -$98.6K |
|
|
TWOA
2867
DELISTED
two
TWOA
| $271K | ﹤0.01% |
27,862
| – | – |
|
2868
Daktronics
DAKT
$1.04B
| $270K | ﹤0.01% |
+53,441
| New | +$281K |
|
2869
GDS Holdings
GDS
$6.28B
| $270K | ﹤0.01% |
5,723
-20,438
| -78% | -$1.13M |
|
|
INN
2870
Summit Hotel Properties
INN
$670M
| $270K | ﹤0.01% |
27,705
-61,134
| -69% | -$593K |
|
|
OGI
2871
Organigram Holdings
OGI
$144M
| $270K | ﹤0.01% |
+38,449
| New | +$326K |
|
2872
Ecovyst
ECVT
$1.11B
| $269K | ﹤0.01% |
26,311
-56,674
| -68% | -$620K |
|
2873
QuinStreet
QNST
$1.27B
| $269K | ﹤0.01% |
14,777
-22,120
| -60% | -$367K |
|
2874
Kimberly-Clark
KMB
$36B
| $268K | ﹤0.01% |
1,878
-5,863
| -76% | -$789K |
|
2875
PRA Group
PRAA
$720M
| $268K | ﹤0.01% |
5,338
-25,005
| -82% | -$1.11M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2021 Portfolio in Review
As of Q4 2021, Cubist Systematic Strategies held 3,782 positions worth $10.5B, up 32% from $7.94B the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.
Cubist Systematic Strategies deployed $2.52B of net new capital in Q4 2021, opening 851 new positions and adding to 1,449 existing holdings. Its largest new stake was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Estee Lauder, an estimated $28M trimmed.
- Cubist Systematic Strategies's largest Q4 2021 buy was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
- Cubist Systematic Strategies added most to Medtronic in Q4 2021, an estimated $38.7M increase.
- Cubist Systematic Strategies's biggest Q4 2021 reduction was Estee Lauder, cutting an estimated $28M.
- Cubist Systematic Strategies fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $5.95M.
- Cubist Systematic Strategies's ten largest holdings make up 3.3% of its $10.5B portfolio in Q4 2021.
- Cubist Systematic Strategies opened 851 new positions and closed 344 in Q4 2021.
- Cubist Systematic Strategies's portfolio value rose 32% quarter-over-quarter to $10.5B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.